ALHC stock soars to 52-week high, hitting $15.84

Published 28/02/2025, 17:56
ALHC stock soars to 52-week high, hitting $15.84

In a remarkable display of market confidence, Alignment Healthcare LLC (ALHC) stock has reached a 52-week high, touching $15.84 amidst a flurry of investor interest. The company, now valued at $3 billion, has demonstrated impressive revenue growth of 48% over the last twelve months, though InvestingPro analysis suggests the stock may be trading above its Fair Value. This peak represents a significant milestone for the healthcare company, which has seen an impressive 1-year change, with its stock value surging by 160.33%. The company’s robust performance and consequent investor enthusiasm underscore a period of strong growth and potential for Alignment Healthcare, as it continues to expand its footprint in the competitive healthcare sector. With analyst targets ranging from $9 to $18 and an overall financial health score of "GOOD" according to InvestingPro, which offers 8 additional key insights about ALHC in their comprehensive Pro Research Report.

In other recent news, Alignment Healthcare reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an EPS of -0.16, compared to the forecast of -0.18. The company’s revenue also exceeded projections, reaching $701.2 million against the expected $674.97 million. For the full year, Alignment Healthcare’s revenue was $2.7 billion, marking a 48% increase year-over-year, with the company achieving its first year of adjusted EBITDA profitability. The company has set its 2025 revenue guidance between $3.72 billion and $3.78 billion, anticipating continued growth in membership and adjusted gross profit. Analysts have taken note of these results, with the company achieving a significant milestone in adjusted EBITDA profitability. Alignment Healthcare’s membership grew by 59% in 2024, with notable expansion outside California, particularly in Nevada. The company ended the year with $471 million in cash and investments, positioning itself well for future growth. Looking ahead, Alignment Healthcare forecasts a continued positive trajectory, with a focus on expanding its market presence and maintaining high STARS ratings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.